Oppgave: MED5600_OPPGAVE04_V18_ORD
|
|
- Timothy Morris Wright
- 5 years ago
- Views:
Transcription
1 Side 23 av 63 Oppgave: MED5600_OPPGAVE04_V18_ORD Del 1: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. What do you do? (Two correct answers) Order a genetic test for BRCA1/2 to rule out hereditary ovarian cancer. Take a pipelle biopsy. Refer the patient to a gynecologist for further assessment. Obtain a urine culture. Take a cervical smear. Refer the patient to a gynecologist for further assessment. Take a cervical smear. Del 2: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. You take a cervical smear and at the same time refer Sofie to the next gynecology department. Following colposcopy and biopsy, she undergoes conization. A section from this specimen is shown.
2 Side 24 av 63 When looking at the microscopic pictures, which two of the following statements are true? The tumor shown is trophoblastic The tumor has its origin in the endocervical columnar epithelium An in situ component can be seen Horn pearls, suggesting squamous differentiation, can be seen Evidence of serous differentiation in the form of concentric calcifications (psammoma bodies) is evident An in situ component can be seen Horn pearls, suggesting squamous differentiation, can be seen
3 Side 25 av 63 Del 3: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. You take a cervical smear and at the same time refer Sofie to the next gynecology department. Following colposcopy and biopsy, she undergoes conization. A section from this specimen is shown. An in situ component (HSIL) can be seen and the tumor contains elements of squamous differentiation. What is the diagnosis? Choriocarcinoma. Squamous cell carcinoma. Adenocarcinoma of endocervical (usual) type. High-grade serous carcinoma Endometrioid adenocarcinoma. Squamous cell carcinoma. Del 4: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. You take a cervical smear and at the same time refer Sofie to the next gynecology department. Following colposcopy and biopsy, she undergoes conization. A section from this specimen is shown. An in situ component (HSIL) can be seen and the tumor contains elements of squamous differentiation. Sofie is diagnosed with a squamous cell carcinoma. Which three statements are true regarding this condition? The tumor is related to HPV infection in 50% of cases. Tumor risk is unrelated to smoking Tumor risk is increased in patients with HIV infection. Screening has reduced the incidence of this tumor in developed countries. Prognosis is excellent irrespective of disease stage. Tumor risk is related to the number of sexual partners. Surgery is the only treatment approach. Tumor risk is increased in patients with HIV infection. Screening has reduced the incidence of this tumor in developed countries. Tumor risk is related to the number of sexual partners.
4 Side 26 av 63 Del 5: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. You take a cervical smear and at the same time refer Sofie to the next gynecology department. Following colposcopy and biopsy, she undergoes conization. A section from this specimen is shown. An in situ component (HSIL) can be seen and the tumor contains elements of squamous differentiation. Sofie is diagnosed with a squamous cell carcinoma. Tumor risk is increased in patients with HIV infection, screening has reduced the incidence and tumor risk is related to the number of sexual partners. The diagnosis of a squamous cell carcinoma of the cervix was unexpected and the resection margins of the cone were not free. Sofie is referred to a gynoncologist. Which three are the next steps in the assessment of the patient? General examination in general anesthesia, cystocopy and rectoscopy if necessary MR examination of the pelvis Resection of the tumor in general anesthesia Whole body PET CT chest/abdomen/pelvis General examination in general anesthesia, cystocopy and rectoscopy if necessary MR examination of the pelvis CT chest/abdomen/pelvis Del 6: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated to menstruation. She also had malodorous vaginal discharge in recent weeks. She has not been to a gynecologist in 3 years. When you ask about cervical smears or HPV testing she cannot recall the last time she was tested. You perform a gynecological examination and find a uterine cervix which bleeds easily, is firm and irregular at palpation and has partly a verrucous surface. You take a cervical smear and at the same time refer Sofie to the next gynecology department. Following colposcopy and biopsy, she undergoes conization. A section from this specimen is shown. An in situ component (HSIL) can be seen and the tumor contains elements of squamous differentiation. Sofie is diagnosed with a squamous cell carcinoma. Tumor risk is increased in patients with HIV infection, screening has reduced the incidence and tumor risk is related to the number of sexual partners. A general examination in anesthesia, an MR of the pelvis and a CT -scan of the thorax is performed, but with no signs of metastatic disease. As a result of these examinations, a small residual tumor in the cervix is identified, but no tumor extension outside the uterus or any sign of metastatic disease is found. Which treatment would you suggest in this situation? Radiation therapy of the cervix. Extended hysterectomy with parametria and removal of fallopian tubes. Extended hysterectomy with parametria, fallopian tubes and lymph nodes in the small pelvis. Trachelectomy Radiation therapy of the cervix with adjuvant cytostatic treatment. Extended hysterectomy with parametria, fallopian tubes and lymph nodes in the small pelvis.
5 Side 27 av 63 Del 7: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. What do you do? (two correct answers) Refer her to a gynecologist for further assessment. Check serum levels of CA 125 Take anamnesis with focus on family history of cancer Take a biopsy from the endometrium (pipelle) and a blood sample for biomarkers in regard to ovarian cancer, and refer her to a gynecologist for further assessment. Remove the IUD and initiate antibiotic treatment against suspicion of salpingitis. Take a cytology-sample from the cervix, remove the IUD, take a blood sample for serum CA 125 levels. Refer her to a gynecologist for further assessment. Take a biopsy from the endometrium (pipelle) and a blood sample for biomarkers in regard to ovarian cancer, and refer her to a gynecologist for further assessment. Del 8: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. Maria is referred to a gynecology department with clinical suspicion of ovarian cancer. She has increased levels of CA 125 and HE4, and normal CEA level. The pelvis mass is found to be a partially cystic ovarian tumor, with tumor growth shown on the ovarian surface. A section from the tumor is submitted to microscopy.
6 Side 28 av 63 When looking at the microscopic pictures, which two of the following statements are true? The tumor cells look typically mucinous The tumor cells are highly pleomorphic The tumor cells are highly atypical The tumor cells grow highly differentiated, with minor atypia The tumor cell appearance indicate a seminoma (dysgerminoma) in the ovary The tumor cells are highly pleomorphic The tumor cells are highly atypical Del 9: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. Maria is referred to a gynecology department with clinical suspicion of ovarian cancer. She has increased levels of CA 125 and HE4, and normal CEA level. The pelvis mass is found to be a partially cystic ovarian tumor, with tumor growth shown on the ovarian surface. A section from the tumor is submitted to microscopy. The tumor cells are highly pleomorphic and atypical.
7 Side 29 av 63 What is the diagnosis? Mucinous cystadenoma. Serous cystadenoma. Serous adenocarcinoma, high-grade. Mature teratoma Malignant granulosa cell tumor. Seminoma of the ovary (dysgerminoma) Serous adenocarcinoma, high-grade.
8 Side 30 av 63 Del 10: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. Maria is referred to a gynecology department with clinical suspicion of ovarian cancer. She has increased levels of CA 125 and HE4, and normal CEA level. The pelvis mass is found to be a partially cystic ovarian tumor, with tumor growth shown on the ovarian surface. A section from the tumor is submitted to microscopy. The tumor cells are highly pleomorphic and atypical. Maria has a high-grade serous adenocarcinoma. Which two statements are true regarding serous carcinomas of the ovaries? High-grade serous adenocarcinomas all have their origin in the ovarian surface epithelium. High-grade serous adenocarcinomas may have their origin in atypical epithelial cells in the tubal fimbria. The risk for developing high-grade serous adenocarcinoma is lower for women who have many ovulations. Women with germline BRCA1 or BRCA2 mutations have increased risk for developing high-grade serous adenocarcinoma. The prognosis is not altered if the tumor grows on the ovarian surface. High-grade serous adenocarcinomas may have their origin in atypical epithelial cells in the tubal fimbria. Women with germline BRCA1 or BRCA2 mutations have increased risk for developing high-grade serous adenocarcinoma. Del 11: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. Maria is referred to a gynecology department with clinical suspicion of ovarian cancer. She has increased levels of CA 125 and HE4, and normal CEA level. The pelvis mass is found to be a partially cystic ovarian tumor, with tumor growth shown on the ovarian surface. A section from the tumor is submitted to microscopy. The tumor cells are highly pleomorphic and atypical. Maria has a high-grade serous adenocarcinoma. High-grade serous adenocarcinomas have their origin in atypical epithelial cells in the tubal fimbria and women with germline BRCA1 or BRCA2 mutations have increased risk for developing this tumor. An ascites is suspected. Which are the most likely reasons for ascites in this case? Consider each symptom. Production of fluid by tumor cells [Nedtrekkliste] Increased production of fluid by serosal cells [Nedtrekkliste] Metastases to the liver [Nedtrekkliste] Tumor plugging of vessels in the hilar region of the liver [Nedtrekkliste] Carcinomatosis in the abdomen [Nedtrekkliste] Nedtrekkliste: Correct Incorrect Production of fluid by tumor cells = Correct
9 Side 31 av 63 Increased production of fluid by serosal cells = Correct Metastases to the liver = Incorrect Tumor plugging of vessels in the hilar region of the liver = Carcinomatosis in the abdomen = Correct Incorrect Del 12: Maria, 52 years, para2, comes to your office for regular cervical screening and removal of an IUD. She complains about irregular menstrual bleeding. She feels constipated and complains about fatigue, but thinks her problems may be related to menopause and to the fact that her older sister recently was diagnosed with cancer of the breast. Upon genitourinary examination you palpate a mass on the right side of the pelvis. Maria is referred to a gynecology department with clinical suspicion of ovarian cancer. She has increased levels of CA 125 and HE4, and normal CEA level. The pelvis mass is found to be a partially cystic ovarian tumor, with tumor growth shown on the ovarian surface. A section from the tumor is submitted to microscopy. The tumor cells are highly pleomorphic and atypical. Maria has a high-grade serous adenocarcinoma. High-grade serous adenocarcinomas have their origin in atypical epithelial cells in the tubal fimbria and women with germline BRCA1 or BRCA2 mutations have increased risk for developing this tumor. An ascites is suspected. Increased production of fluid by tumor cells and serosal cells, and a diagnosis of carcinomatosis are likely causes of ascites. Which group of tumors does the high-grade serous carcinoma belongs to? Germ cell tumors Non-seminomas (dysgerminoma) Sex-cord stromal tumors Epithelial stromal tumors Sarcomas Primitive, blue cell tumors Epithelial stromal tumors
10 Side 61 av 63 Oppgave: MED5600_OPPGAVE11_V18_ORD Del 1: Medical ethics, non-sequential questions Within the context of global research, choose the two correct statements: Informed consent is primarily meant to protect the researcher and the institution from a lawsuit; Informed consent is a tool meant to respect the participant's autonomy. Informed consent may be justifiably waived (given up) due to reasons of social value. Informed consent must be guided by respect for the knowledge and voluntariness of the research participants. For reasons related to cultural differences between countries, it may be acceptable to waive (give up) individual informed consent. Informed consent is a tool meant to respect the participant's autonomy. Informed consent must be guided by respect for the knowledge and voluntariness of the research participants. Spørsmål 2: Within the context of global research, choose the two correct statements: The Fair Benefits approach ensures post-trial access to drugs and takes into account the powerdifferential between the contracting partners. Responsiveness refers to the principle that, prior to a clinical trial, the sponsor/principal investigator must ensure that potential benefits are shared to the research participants after the study. Post-trial access requires the pre-trial consideration and planning of how potential benefits may be shared with trial participants/population. Responsiveness requires the sponsor/clinical investigator to know the national need for an intervention in a country prior to performing the clinical trial there. The TRIPS Agreement, which sets out requirements for Intellectual Property rights, ensures post-trial access to study drugs in low and middle-income countries. Post-trial access requires the pre-trial consideration and planning of how potential benefits may be shared with trial participants/population. Responsiveness requires the sponsor/clinical investigator to know the national need for an intervention in a country prior to performing the clinical trial there. Spørsmål 3: Empathy is an important capacity in clinical medicine. Why is this so? Choose the two most correct answers. Empathy connects the physician and the patient. Empathy is crucial in creating a therapeutic relationship. Empathy provides an access to the experiences and personal perspectives of the patient. Empathy consists of affective and cognitive components and facilitates moral motivation. Empathy is to put oneself in the shoes of another person Empathy enforces moral responsibility in the clinical encounter Empathy provides an access to the experiences and personal perspectives of the patient. Empathy consists of affective and cognitive components and facilitates moral motivation.
11 Side 62 av 63 Del 2: General practice, non-sequential questions about breastfeeding. What is the name of the milk produced the first 3 days postpartum? Hindmilk Colostrum Foremilk Premilk Colostrum Spørsmål 2: How often is it recommended that the baby feeds the first days and weeks of life? Every 3 hours Every 2 hours 8-12 times a day Whenever the child cries 8-12 times a day Spørsmål 3: Which two statements are correct? Breastfeeding is not compatible with the mother taking antibiotics treating mastitis. The baby may suck from the breast even if the mother has mastitis caused by MRSA. Amoxicillin is the first-choice antibiotic for treatment of mastitis. Ibuprofen may not be used as a painkiller while breastfeeding. Dicloxacillin is the first-choice antibiotic for treatment of mastitis. The baby may suck from the breast even if the mother has mastitis caused by MRSA. Dicloxacillin is the first-choice antibiotic for treatment of mastitis. Spørsmål 4: 3-4 days postpartum most mothers experience painful swelling of the breasts. This is called lactogenesis 2 and happens when the production of mature milk starts. What causes the swelling of the breasts? Infection. Excessive milk in the breasts and milk stasis. Venous and lymphatic stasis. Growth of the milk ducts Venous and lymphatic stasis. Spørsmål 5: How do you differentiate between an inflammatory and an infectious mastitis? Infectious mastitis is usually preceded by other breastfeeding problems. In infectious mastitis the CRP is more than 100.
12 Side 63 av 63 In infectious mastitis there is always pus in the milk. In infectious mastitis the CRP is more than 50. Infectious mastitis is usually preceded by other breastfeeding problems. Spørsmål 6: What is the primary treatment of a lactational mastitis? Antibiotics Emptying of the breast every second hour Painkillers and avoid touching the breast Stop breastfeeding Emptying of the breast every second hour
Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationGynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
More informationPathology of the female genital tract
Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationWhat Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationPathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh
Pathology of Ovarian Tumours Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh Outline Incidence Risk factors Classification Pathology of tumours Tumour markers Prevention
More information3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors (neoplasms) 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationGynaecological Malignancies
Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors
More informationInstitute of Pathology First Faculty of Medicine Charles University. Ovary
Ovary Barrett esophagus ph in vagina between 3.8 and 4.5 ph of stomach varies from 1-2 (hydrochloric acid) up to 4-5 BE probably results from upward migration of columnar cells from gastroesophageal junction
More informationFemale Reproduc.ve System. Kris.ne Kra7s, M.D.
Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Cervical Carcinoma Once the most common cancer in women now not even in top 10. Decrease due
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationCervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
More information3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal cells
More informationGYNECOLOGIC MALIGNANCIES: Ovarian Cancer
GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss
More informationCytology and Surgical Pathology of Gynecologic Neoplasms
Cytology and Surgical Pathology of Gynecologic Neoplasms Current Clinical Pathology ANTONIO GIORDANO, MD, PHD SERIES EDITOR For further titles published in this series, go to http://www.springer.com/springer/series/7632
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationOvarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors
Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors Overview Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer are
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationWhat is cervical cancer?
What is cervical cancer? The cervix is the bottom part, or neck, of the uterus. Cervical cancer happens when normal cells in the cervix change into abnormal cells, and grow out of control. Most women whose
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationCervical Conization. 1
Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationFemale Reproduc.ve System. Kris.ne Kra7s, M.D.
Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Female Reproduc.ve System Outline Cervix Cervical carcinoma Cervical Carcinoma Once the most
More information1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
More informationCervical Cancer. Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year.
Cervical Cancer Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year. Most cases of cervical cancer can be prevented by getting regular
More informationPassport to Health Preventing and Recognizing Gynecologic Cancers
Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can
More informationL/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital
L/O/G/O Ovarian Tumor Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital Essentials classification of ovarian tumor clinical manifestation of ovarian tumor metastatic
More informationSee the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.
About Ovarian Cancer Overview and Types If you have been diagnosed with ovarian cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What Is
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationGynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1
What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical
More informationMousa. Najat kayed &Renad Al-Awamleh. Nizar Alkhlaifat
6 Mousa Najat kayed &Renad Al-Awamleh Nizar Alkhlaifat P a g e 1 This sheet written based on record 13 on website Cover slide( 95-117 ) No need to go back to slide FALLOPIAN TUBE PATHOLOGY In general fallopian
More informationPRIMARY ADENOCARCINOMA OF THE FALLOPIAN TUBE - A CASE REPORT
PRIMARY ADENOCARCINOMA OF THE FALLOPIAN TUBE - A CASE REPORT MANDAKINI BT, HAKEEM A, RAJASHREE P, SHAGUFTA R, PATTANKAR VL DEPARTMENT OF PATHOLOGY & OBSTETRICS AND GYNECOLOGY KHAJA BANDANAWAZ INSTITUTE
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationGynecological Cancers in Primary Care
Gynecological Cancers in Primary Care Nora M. Lersch MSN CRNP AOCNP Division of Gynecological Oncology Objectives Identify the incidence of ovarian, cervical, vulvar and endometrial cancer Identify common
More informationCervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.
Cervical Cancer Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. The cervix is the lower, narrow end of the uterus (the hollow, pear-shaped organ where
More informationSpringer Healthcare. Understanding and Diagnosing Ovarian Cancer. Concise Reference: Krishnansu S Tewari, Bradley J Monk
Concise Reference: Understanding and Diagnosing Ovarian Cancer Krishnansu S Tewari, Bradley J Monk Extracted from: The 21 st Century Handbook of Clinical Ovarian Cancer Published by Springer Healthcare
More informationAnnual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationWhat You Need to Know About Ovarian Cancer
What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationGynecologic Malignancies. Kristen D Starbuck 4/20/18
Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial
More informationVagina. 1. Introduction. 1.1 General Information and Aetiology
Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.
More informationGynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer
Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy
More informationIndex. Cytoplasm, nonepithelial malignant tumor features 70
Accurette device 23 Adenosarcoma, differential diagnosis 80, 81 Arias-Stella reaction 65 Atypical endocervical cells 8 Atypical endometrial cells 8 Atypical glandular cells (AGC) 8, 9 Atypical glandular
More informationDone by khozama jehad. Neoplasia of the cervix
Done by khozama jehad Neoplasia of the cervix An overview of cervical neoplasia very import. Most tumors of the cervix are of epithelial origin and are caused by oncogenic strains of human papillomavirus
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More informationCERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.
CERVIX MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb. CERVIX Most cervical lesions are: Most are Cervicitis. cancers ( common in women worldwide). CERVICITIS Extremely
More informationuterine cancer endometrial cancer
2018 ICD-10-CM Diagnosis Code. Adenocarcinoma of endometrium ; Cancer of the. (mucous membrane that lines the endometrial cavity). ICD-10-CM C54.1 is grouped. Home ICD 9 Codes Endometrial Cancer ICD 9
More information7 Mousa. Obada Zalat. Mohammad Badi
7 Mousa Obada Zalat Mohammad Badi Tumors of the ovaries Last lecture we talked about surface epithelial tumors of the ovaries (the most common type). But there are many other types of tumors of germ cell
More informationHow to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens
How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens Wenxin Zheng, M.D. Professor of Pathology and Gynecology University of Arizona zhengw@email.arizona.edu http://www.zheng.gynpath.medicine.arizona.edu/index.html
More informationEstimated New Cancers Cases 2003
Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz Estimated New Cancers Cases 2003 Images removed due to copyright reasons.
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.
Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationIf you do not have time for the entire presentation refer to the following table of contents. To navigate through the slides, right click on your
Welcome This is an online version of a lecture given by Dr Keith Merritt on gyn cancers. Its purpose is to help women become more aware of early symptoms, risk factors, screening strategies and the importance
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationCase Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue
Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized
More informationMajor tips: The importance of early detection: Hx, risk factors
Cancer Chapter 3 Introduction Cancer ranks 2nd to cardiovascular disease as the leading cause of death in the Gaza Strip. Death rate increased from 10.3% in 2007 to 13.6 in 2012. Some related factors :
More informationMolly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine
Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine Review causes of abnormal uterine bleeding: Adolescent Reproductive
More informationEndosalpingiosis. Case report
Case report Endosalpingiosis Michael D. Holmes, M.D. Howard S. Levin M.D. Department of Pathology Lester A. Ballard, Jr., M.D. Department of Gynecology Endosalpingiosis, a term referring to tuballike epithelium
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationBCCCP Approved ICD-9 Code List Fiscal Year 2010
BCCCP Approved ICD-9 List Fiscal Year 2010 Diagnosis Description 174.0 Malignant neoplasm of female breast; Nipple and areola 174.1 Malignant neoplasm of female breast; Central portion 174.2 Malignant
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationAdenocarcinoma of the Cervix
Question 1. Each of the following statements about cervical adenocarcinoma is true except: Adenocarcinoma of the Cervix SAMS a) A majority of women with cervical adenocarcinoma have stage I tumors at diagnosis.
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationMethods of Obstetrics & Gynecology treatment
Methods of Obstetrics & Gynecology treatment Gynecology is the medical practice dealing with the health of the female reproductive systems (vagina, uterus and ovaries) and the breasts Lector: MD Ganna
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationWhat is ovarian cancer?
What is ovarian cancer? Ovarian cancer is a type of cancer that forms in tissues of the ovary. Most ovarian cancers are either ovarian epithelial cancers (cancer that begins in the cells on the surface
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2
More information4 Mousa Al-abbadi. Ola Al-juneidi. Abdul-rahman Ibrahim
4 Mousa Al-abbadi Ola Al-juneidi Abdul-rahman Ibrahim Cervical Cancer We previously talked about human papilloma virus (HPV). There are almost 140 serotypes of HPV so far. Certain serotypes (14 of them)
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationCase 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow
Case 3 - GYN History: 66 year old, routine Pap test Dr. Stelow Case 3 66 year year old woman Routine Pap Test Cytologic Features 3 dimensional clusters of cells with small to moderate amount of
More informationreproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.
Thematic plan of lectures module iii. Diseases of female reproductive system. Family planning. Topic No of hours 1. Disturbances of menstrual function. Neuroendocrinological 2 syndromes in gynecology 1.
More informationCase year female. Routine Pap smear
Case 1 57 year female Routine Pap smear Diagnosis? 1. Atypical glandular cells of unknown significance (AGUS) 2. Endocervical AIS 3. Endocervical adenocarcinoma 4. Endometrial adenocarcinoma 5. Adenocarcinoma
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationRitu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University
Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States
More informationGeneral history. Basic Data : Age :62y/o Date of admitted: Married status : Married
General history Basic Data : Age :62y/o Date of admitted:940510 Married status : Married General history Chief Complain : bilateral ovarian cyst incidentally being found out during pap smear. Present Illness
More informationRole and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh
Role and Techniques of Surgery in Carcinoma Cervix Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Points for Discussion Pattern of spread Therapeutic options Types of surgical procedures
More informationCPC on Cervical Pathology
CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade
More informationHitting the High Points Gynecologic Oncology Review
Hitting the High Points is designed to cover exam-based material, from preinvasive neoplasms of the female genital tract to the presentation, diagnosis and treatment, including surgery, chemotherapy, and
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way
ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationOVARIAN CANCER STATISTICS
bioprognos OncoOVARIAN Dx Non-invasive blood test useful to suggest a possible diagnosis in patients with suspected malignancy in the ovarians, reduce inappropriate diagnostic tests, days of hospitalization,
More informationPATHOLOGY OF THE FEMALE GENITAL TRACT
MBBS 2 nd Yr. Lecture Dr. Annie Cheung September 30, 2002 9:30 am LT2,G/F, Academic and Administration Block Faculty of Medicine Building UROGENITAL SYSTEM PATHOLOGY OF THE FEMALE GENITAL TRACT Learning
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationOvarian Cancer Causes, Risk Factors, and Prevention
Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer.
More informationCervical Cancer Prevention Month. January 2011 Morehouse College
Cervical Cancer Prevention Month January 2011 Morehouse College What is Cervical Cancer? Cervical Cancer begins in the cervix (lower part of the womb, called the uterus). Cervical Cancer, at one point,
More informationSection 1. Biology of gynaecological cancers: our current understanding
Section 1 Biology of gynaecological cancers: our current understanding Chapter 1 Morphological sub-types of ovarian carcinoma: new developments and pathogenesis W Glenn McCluggage 1 Introduction In most
More informationPORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:
May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx
More information